| Literature DB >> 29765956 |
Maggie S Matern1, Alisha Beirl2, Yoko Ogawa1, Yang Song3, Nikhil Paladugu1, Katie S Kindt2, Ronna Hertzano1,3,4.
Abstract
The zebrafish inner ear organs and lateral line neuromasts are comprised of a variety of cell types, including mechanosensitive hair cells. Zebrafish hair cells are evolutionarily homologous to mammalian hair cells, and have been particularly useful for studying normal hair cell development and function. However, the relative scarcity of hair cells within these complex organs, as well as the difficulty of fine dissection at early developmental time points, makes hair cell-specific gene expression profiling technically challenging. Cell sorting methods, as well as single-cell RNA-Seq, have proved to be very informative in studying hair cell-specific gene expression. However, these methods require that tissues are dissociated, the processing for which can lead to changes in gene expression prior to RNA extraction. To bypass this problem, we have developed a transgenic zebrafish model to evaluate the translatome of the inner ear and lateral line hair cells in their native tissue environment; the Tg(myo6b:RiboTag) zebrafish. This model expresses both GFP and a hemagglutinin (HA) tagged rpl10a gene under control of the myo6b promoter (myo6b:GFP-2A-rpl10a-3xHA), resulting in HA-tagged ribosomes expressed specifically in hair cells. Consequently, intact zebrafish larvae can be used to enrich for actively translated hair cell mRNA via an immunoprecipitation protocol using an antibody for the HA-tag (similar to the RiboTag mice). We demonstrate that this model can be used to reliably enrich for actively translated zebrafish hair cell mRNA. Additionally, we perform a global hair cell translatome analysis using RNA-Seq and show enrichment of known hair cell expressed transcripts and depletion of non-hair cell expressed transcripts in the immunoprecipitated material compared with mRNA extracted from whole fish (input). Our results show that our model can identify novel hair cell expressed genes in intact zebrafish, without inducing changes to gene expression that result from tissue dissociation and delays during cell sorting. Overall, we believe that this model will be highly useful for studying changes in zebrafish hair cell-specific gene expression in response to developmental progression, mutations, as well as hair cell damage by noise or ototoxic drug exposure.Entities:
Keywords: RNA-Seq; RiboTag; hair cells; inner ear; zebrafish
Year: 2018 PMID: 29765956 PMCID: PMC5939014 DOI: 10.3389/fcell.2018.00047
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Figure 1The Tg(myo6b:RiboTag) zebrafish. (A) Schematic representation of the GFP-2A-rpl10a-3xHA construct driven by the HC-specific myo6b promoter. (B) Representative image of a live Tg(myo6b:RiboTag) zebrafish at 5 dpf showing GFP expression in the inner ear (IE) and lateral line neuromasts (N). (C) Immunohistochemistry using an HA antibody showing that Rpl10a-HA expression overlaps with GFP expression specifically within the HCs of the inner ear and neuromasts. White arrows denote nucleolar Rpl10a-HA staining.
Figure 2HC ribosome immunoprecipitation pulls down HC-specific transcripts. (A) Explanation of the HA-tagged ribosome immunoprecipitation protocol (see Methods for more information). (B) Agilent Bioanalyzer PicoChip outputs showing that input (IN) and immunoprecipitated (IP) RNA quality is comparable between sample types despite reduced levels of 18S rRNA in the IP samples. This observation is consistent with previous zebrafish ribosome immunoprecipitation protocols (Tryon et al., 2013). (C) RT-qPCR results showing that transcripts for known HC-expressed genes such as atoh1a and myo6b are significantly enriched by HA-tagged ribosome immunoprecipitation, whereas transcripts for genes not specifically expressed in HCs are either not significantly enrichened (sox2, myod1) or depleted (rho, vil1). Error bars represent fold change ± standard deviation, and statistical significance was assessed by two-tailed Welch's t-test (n = 10). *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001.
Figure 3HC ribosome immunoprecipitation can reliably detect HC enriched and depleted transcripts by RNA-Seq. (A) Bar graph showing the distribution of significantly enriched and depleted transcripts in the IN vs. IP samples binned by fold change range. For genes with depleted transcripts in the IP samples, the number of genes per bin is as follows: 2x − 5x = 1726, 5x − 10x = 422, 5x − 10x = 109, and 50x + = 1. For IP enriched gene transcripts, the number of genes per bin is as follows: 2x − 5x = 1685, 5x − 10x = 450, 5x − 10x = 223, and 50x + = 21. (B) RNA-Seq fold change enrichment and depletion of HC expressed and non-expressed genes replicates the results obtained by RT-qPCR (Figure 2C). Statistical significance was assessed using DEseq (see Methods). *FDR < 0.05, **FDR < 0.01, ***FDR < 0.001.
Gene ontology analysis of hair cell enriched genes.
| miRNA mediated inhibition of translation | 9 | 5 | 0.21 | 24.32 | 0.00252 | |
| Skeletal muscle contraction | 23 | 5 | 0.53 | 9.52 | 0.0373 | |
| 25 | 5 | 0.57 | 8.76 | 0.0496 | ||
| 48 | 7 | 1.1 | 6.37 | 0.0283 | ||
| 62 | 8 | 1.42 | 5.64 | 0.0237 | ||
| Steroid hormone mediated signaling pathway | 77 | 9 | 1.76 | 5.11 | 0.0198 | |
| mRNA metabolic process | 299 | 19 | 6.84 | 2.78 | 0.0182 | |
| Transcription, DNA-templated | 841 | 43 | 19.24 | 2.23 | 0.00093 | |
| Regulation of transcription, DNA-templated | 1703 | 71 | 38.97 | 1.82 | 0.00092 |
Gene ontology analysis of hair cell depleted genes.
| Antibiotic catabolic process | 4 | 3 | 0.07 | 41.55 | 0.024 | |
| ATP synthesis coupled electron transport | 43 | 7 | 0.78 | 9.02 | 0.00537 | |
| 38 | 6 | 0.69 | 8.75 | 0.0176 | ||
| Pyruvate metabolic process | 43 | 6 | 0.78 | 7.73 | 0.0275 | |
| ATP biosynthetic process | 64 | 8 | 1.16 | 6.93 | 0.00767 | |
| 97 | 12 | 1.75 | 6.85 | 0.00022 | ||
| Proton transmembrane transport | 57 | 7 | 1.03 | 6.8 | 0.0194 | |
| Regulation of cell growth | 97 | 9 | 1.75 | 5.14 | 0.0179 | |
| Coenzyme biosynthetic process | 116 | 9 | 2.1 | 4.3 | 0.0436 | |
| Nucleobase-containing compound catabolic process | 153 | 11 | 2.77 | 3.98 | 0.0239 | |
| Cellular protein localization | 497 | 23 | 8.99 | 2.56 | 0.0115 | |
| Protein transport | 530 | 24 | 9.59 | 2.51 | 0.0113 | |
| System development | 2,933 | 79 | 52.94 | 1.49 | 0.0437 |
ZEOGS analysis of HC enriched transcripts.
| Neuromast | 0.00052 | |
| Levator operculi | 0.06849 | |
| Hair cell anterior macula | 0.07032 | |
| Hyohyoideus | 0.07515 | |
| Olfactory epithelium | 0.0832 | |
| Olfactory bulb | 0.0915 | |
| Hair cell posterior macula | 0.09839 |
Fold change enrichment of human deafness gene homologs in Tg(myo6b:RiboTag) IP samples.
| ENSDARG00000074638 | AR non-syndromic deafness | 77.35484 | 3.01E−57 | NA | |||
| ENSDARG00000094738 | AR non-syndromic deafness | 47.78006 | 8.84E−20 | NA | |||
| ENSDARG00000056386 | AD and AR non-syndromic deafness | 15.46066 | 0.00102 | Maeda et al., | |||
| ENSDARG00000053074 | AR non-syndromic deafness | 15.4136 | 4.61E−26 | NA | |||
| ENSDARG00000105391 | AR non-syndromic deafness | 14.00558 | 7.37E−16 | NA | |||
| ENSDARG00000056458 | AR non-syndromic deafness | 12.75537 | 2.74E−07 | NA | |||
| ENSDARG00000020581 | AR non-syndromic deafness | 12.37504 | 4.49E−29 | Chatterjee et al., | |||
| ENSDARG00000105434 | AR non-syndromic deafness | 10.61186 | 4.21E−07 | NA | |||
| ENSDARG00000053692 | AR non-syndromic deafness | 10.00353 | 0.011347 | 0.052075 | NA | ||
| ENSDARG00000074742 | AR non-syndromic deafness | 7.635278 | 0.043045 | 0.145634 | NA | ||
| ENSDARG00000053315 | AR non-syndromic deafness | 7.302665 | 2.63E−15 | NA | |||
| ENSDARG00000008849 | AR non-syndromic deafness | 6.882463 | 0.030491 | 0.11237 | NA | ||
| ENSDARG00000008127 | Usher syndrome type 1F and 1D, AR non-syndromic deafness | 6.751992 | 6.03E−09 | Seiler et al., | |||
| ENSDARG00000076414 | AR non-syndromic deafness | 6.702256 | 0.00318 | NA | |||
| ENSDARG00000030832 | AR non-syndromic deafness | 6.1553 | 6.87E−12 | Thisse and Thisse, | |||
| ENSDARG00000040046 | Waardenburg syndrome | 5.542076 | 1.21E−13 | NA | |||
| ENSDARG00000052277 | AR non-syndromic deafness | 5.462416 | 1.59E−13 | Di Donato et al., | |||
| ENSDARG00000045023 | AR non-syndromic deafness | 5.390774 | 0.002062 | Erickson and Nicolson, | |||
| ENSDARG00000075870 | AR non-syndromic deafness | 5.012163 | 6.12E−13 | NA | |||
| ENSDARG00000005335 | AR non-syndromic deafness | 4.781316 | 0.000239 | NA | |||
| ENSDARG00000029482 | Usher syndrome type 2A | 4.61055 | 0.047798 | 0.157459 | Blanco-Sánchez et al., | ||
| ENSDARG00000105136 | AD non-syndromic deafness | 4.590251 | 9.01E−11 | NA | |||
| ENSDARG00000006385 | AR non-syndromic deafness | 3.836217 | 5.98E−08 | NA | |||
| ENSDARG00000042141 | AD and AR non-syndromic deafness | 3.512935 | 0.007429 | Seiler et al., | |||
| ENSDARG00000010192 | Waardenburg syndrome | 3.496733 | 0.038943 | 0.134993 | NA | ||
| ENSDARG00000012397 | AD non-syndromic deafness | 3.495119 | 0.000225 | Kozlowski et al., | |||
| ENSDARG00000069423 | AR non-syndromic deafness | 3.285445 | 0.00012 | Shen et al., | |||
| ENSDARG00000068166 | Usher syndrome type 2D, AR non-syndromic deafness | 2.864421 | 0.010032 | Blanco-Sánchez et al., | |||
| ENSDARG00000011407 | Stickler syndrome | 2.802449 | 0.002457 | NA | |||
| ENSDARG00000102128 | AR non-syndromic deafness | 2.782384 | 0.000132 | NA | |||
| ENSDARG00000010186 | AR non-syndromic deafness | 2.523912 | 0.011106 | 0.051163 | NA | ||
| ENSDARG00000045302 | X-linked non-syndromic deafness | 2.435658 | 0.000595 | NA | |||
| ENSDARG00000042707 | AD keratitis-ichthyosis-deafness syndrome, AD and AR nonsyndromic deafness | 2.33159 | 0.000102 | Tao et al., | |||
| ENSDARG00000002831 | Alport syndrome | 2.309518 | 0.032912 | 0.119212 | NA | ||
| ENSDARG00000003395 | Alport syndrome | 2.136137 | 0.03126 | 0.114457 | NA | ||
| ENSDARG00000026165 | Stickler syndrome | 2.073293 | 0.025006 | 0.096541 | Thisse and Thisse, |
AR, autosomal recessive; AD, autosomal dominant.
Figure 4Tg(myo6b:RiboTag) immunoprecipitation avoids gene expression changes from cell sorting. (A) Sets of genes found to be enriched in sorted HCs from Steiner et al. (2014) have significantly higher fold change enrichment in the IP samples compared to remaining expressed genes (background). Significance was determined by Wilcoxon's test. (B) Cell sorting experiment utilizing the Tg(myo6b:RiboTag) model. Populations of both GFP positive (GFP+) and GFP negative (Neg, GFP–) were collected via FACS based on GFP expression. Post sort analysis shows high purity of negative and positive populations (98.2 and 95.3%, respectively). (C–E) RT-qPCR analysis of zebrafish homologs of immediate early and heat shock protein encoding genes in sorted HCs (GFP+, C), sorted non-HCs (GFP–, D), and immunoprecipitated RNA (IP, C) vs. RNA extracted from whole, non-dissociated larvae (IN). Error bars represent fold change ± standard deviation. Statistical significance was assessed by two-tailed Welch's t-test (n = 3). *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001.
Figure 5HC RiboTag immunoprecipitation reveals expression of novel HC expressed genes. (A) Validation of 10 genes found to be highly enriched in HCs from the Tg(myo6b:RiboTag) RNA-Seq using RT-qPCR in independent HC immunoprecipitation (IP) and input (IN) samples. Error bars represent fold change ± standard deviation, and statistical significance was assessed by two-tailed Welch's t-test (n = 3). *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001. (B) Validation of the same 10 highly enriched genes selected from the Tg(myo6b:RiboTag) RNA-Seq in sorted HCs by RT-qPCR. Black bar indicates the cycle threshold (CT) cutoff used to denote reliable expression (CT ≤ 30). Error bars represent CT standard deviation between biological replicates (n = 3).